Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced that effective December 31, 2019 the Company has finalized and executed the previously announced transition of the Peloton hearing screening services business to Pediatrix Medical Group (“Pediatrix”).
Pediatrix Medical Group, a MEDNAX, Inc. company, will manage all newborn hearing screening services for Peloton hospitals while Natus will provide its best-in-class ALGO screeners and supplies to Pediatrix to support its entire hearing screening business. Installation of ALGO screeners at the Pediatrix hospitals is expected to be completed during 2020.
Source: BioSpace